To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ZCCHC17TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
569 supporting clones for gene ZCCHC17 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BU663226 blood .a 1 to 531 13 to 543   tiling clone,   532/543
(97 %)
6 diff
(98.9 %id)
BU164598 large cell carcinoma, lung .a 157 to 1021 43 to 917   tiling clone,   875/918
(95 %)
22 diff
(97.7 %id)
AW651651   .a 162 to 567 1 to 406       406/406
(100 %)
0 diff
(100 %id)
AW672724   .a 1589 to 1840 257 to 6   tiling clone,   252/257
(98 %)
0 diff
(100 %id)
TI_227712936   .b 1 to 839 891 to 62 G2V P8L S9Q V10L G11S ... tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 830/1038
(79 %)
13 diff
(98.8 %id)
CD367302 Alveolar Macrophage, lung .b 127 to 836 711 to 2   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 710/711
(99 %)
2 diff
(99.8 %id)
AF247661 Kidney .c 1 to 1480 11 to 1484 N4T L5C F7S S8Q A9L ... tiling clone,   1474/1484
(99 %)
7 diff
(99.6 %id)
AK302343 testis .d 1 to 1137 1 to 1137 S62P tiling clone,   1137/1137
(100 %)
2 diff
(99.9 %id)
DC399632 testis .d 1 to 514 1 to 514       514/514
(100 %)
1 diff
(99.9 %id)
BP245854 Kidney .e 1 to 582 1 to 582   tiling clone,   582/582
(100 %)
0 diff
(100 %id)
FN110103 breast carcinoma .e 6 to 66 60 to 1     Submitted on the opposite strand 60/60
(100 %)
1 diff
(98.4 %id)
AK022506   .e 10 to 1611 1 to 1602 exact available from FLJ,   1602/1602
(100 %)
1 diff
(100.0 %id)
BM468283 melanotic melanoma, skin .e 10 to 846 1 to 838   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 838/839
(99 %)
6 diff
(99.3 %id)
BU935115 mixed (pool of 40 RNAs) .e 10 to 704 1 to 708       708/840
(84 %)
33 diff
(96.1 %id)
BP280652   .e 10 to 597 1 to 588       588/588
(100 %)
0 diff
(100 %id)
NM_016505.2   .e 10 to 1611 1 to 1602 exact RefSeq,   1602/1602
(100 %)
1 diff
(100.0 %id)
BM741486 Ascites, stomach .e 10 to 623 1 to 614       614/614
(100 %)
0 diff
(100 %id)
BM742921 Ascites, stomach .e 10 to 635 1 to 626       626/626
(100 %)
0 diff
(100 %id)
BM752672 Ascites, stomach .e 10 to 539 1 to 530       530/531
(99 %)
3 diff
(99.5 %id)
BM765009 Ascites, stomach .e 10 to 632 1 to 623       623/623
(100 %)
2 diff
(99.7 %id)
BM781696 Ascites, stomach .e 10 to 566 1 to 557       557/557
(100 %)
0 diff
(100 %id)
BM784283 stomach .e 10 to 630 1 to 621       621/621
(100 %)
0 diff
(100 %id)
BM783636 stomach .e 10 to 304 1 to 295       295/295
(100 %)
0 diff
(100 %id)
BM771960 stomach .e 10 to 432 1 to 423       423/423
(100 %)
0 diff
(100 %id)
AU122883   .e 11 to 594 2 to 585   capped   584/584
(100 %)
4 diff
(99.4 %id)
BM789238 stomach .e 11 to 680 1 to 670       670/670
(100 %)
3 diff
(99.6 %id)
TI_57183571   .e 12 to 836 31 to 861   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 831/866
(95 %)
17 diff
(98.1 %id)
DW422802 Liver .e 13 to 288 18 to 293       276/293
(94 %)
6 diff
(98.0 %id)
DB447802.
matches multiple genes
testis .e 13 to 458 1 to 443     also hits gene FABP3 443/443
(100 %)
2 diff
(99.6 %id)
BI770660 pooled lung and spleen .e 13 to 836 1 to 830       830/835
(99 %)
11 diff
(98.7 %id)
BF213340 bone marrow, from acute myelogenous leukemia .e 14 to 561 1 to 546       546/810
(67 %)
10 diff
(98.8 %id)
DA717150   .e 14 to 561 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DW432176 Liver .e 15 to 262 17 to 266       250/266
(93 %)
10 diff
(96.3 %id)
CF144473 CNCAP(3)T-225 cell line, Prostate .e 17 to 555 1 to 538       538/538
(100 %)
7 diff
(98.7 %id)
CF144575 CNCAP(3)T-225 cell line, Prostate .e 17 to 469 1 to 453       453/453
(100 %)
10 diff
(97.8 %id)
DB057567 testis .e 18 to 550 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
AA167826   .e 19 to 613 1 to 589       589/623
(94 %)
14 diff
(97.8 %id)
BG169202 hypernephroma, cell line, Kidney .e 19 to 637 10 to 629       620/629
(98 %)
8 diff
(98.8 %id)
TI_57177728   .e 19 to 714 31 to 729       699/751
(93 %)
19 diff
(97.5 %id)
CD627972   .e 20 to 564 7 to 550       544/553
(98 %)
8 diff
(98.6 %id)
AK024049   .e 21 to 1611 1 to 1591 exact available from FLJ,   1591/1591
(100 %)
1 diff
(100.0 %id)
BP310205 brain .e 21 to 602 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP347137 brain .e 21 to 603 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BP347161 brain .e 21 to 602 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
DA005726   .e 22 to 588 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA402936 thalamus .e 22 to 609 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
BP264284 small intestine .e 22 to 603 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA748618   .e 22 to 594 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
AU143463   .e 22 to 837 2 to 827   capped   826/826
(100 %)
12 diff
(98.6 %id)
BG323636 Kidney, renal cell adenocarcinoma .e 23 to 706 1 to 685       685/706
(97 %)
13 diff
(98.2 %id)
BG323551 Kidney, renal cell adenocarcinoma .e 23 to 710 1 to 683       683/817
(83 %)
11 diff
(98.7 %id)
AL048938 testis .e 24 to 665 1 to 640       640/640
(100 %)
4 diff
(99.4 %id)
BI766416 pooled lung and spleen .e 24 to 714 1 to 694       694/716
(96 %)
13 diff
(98.2 %id)
TI_154176559   .e 24 to 614 35 to 624       590/590
(100 %)
3 diff
(99.5 %id)
CX762992 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 25 to 787 1 to 756     Submitted on the opposite strand 756/756
(100 %)
20 diff
(97.4 %id)
CR626544 Neuroblastoma Cot 25-normalized .e 26 to 1571 1 to 1546 exact     1546/1546
(100 %)
0 diff
(100 %id)
BX353205 Neuroblastoma Cot 25-normalized .e 26 to 911 1 to 875 K224X fully sequenced,   875/875
(100 %)
2 diff
(99.8 %id)
BX375308 Neuroblastoma Cot 25-normalized .e 26 to 708 1 to 683       683/683
(100 %)
1 diff
(99.9 %id)
DW429328 Liver .e 27 to 420 11 to 404       394/404
(97 %)
10 diff
(97.6 %id)
CX759809 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 29 to 709 1 to 678     Submitted on the opposite strand 678/755
(89 %)
14 diff
(98.2 %id)
BG714675 brain, hypothalamus .e 31 to 626 1 to 606       606/606
(100 %)
17 diff
(97.2 %id)
CR602299 Placenta Cot 25-normalized .e 32 to 1599 1 to 1568 exact     1568/1568
(100 %)
0 diff
(100 %id)
BX399658 Placenta Cot 25-normalized .e 32 to 1126 1 to 1090 K139*     1090/1091
(99 %)
25 diff
(97.8 %id)
BG709292 brain, hypothalamus .e 33 to 699 1 to 668       668/679
(98 %)
7 diff
(99.0 %id)
CF597097 ovary .e 34 to 562 1 to 532       532/848
(62 %)
14 diff
(98.4 %id)
TI_57195944   .e 34 to 714 29 to 716       688/741
(92 %)
20 diff
(97.4 %id)
BG943561 blood .e 36 to 564 1 to 529       529/533
(99 %)
5 diff
(99.1 %id)
CR609881 Neuroblastoma Cot 50-normalized .e 37 to 1573 1 to 1537 exact     1537/1537
(100 %)
0 diff
(100 %id)
BX395483 Neuroblastoma Cot 50-normalized .e 37 to 1187 1 to 1133 Q41X K134X K135X K139Q G140E ...     1133/1136
(99 %)
40 diff
(96.5 %id)
BI818117 pooled brain, lung, testis .e 37 to 714 1 to 685       685/710
(96 %)
16 diff
(97.8 %id)
DB036299 testis .e 37 to 608 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
CD695296 normal nasopharynx .e 38 to 460 38 to 460       423/460
(91 %)
7 diff
(98.5 %id)
BF680016 Prostate .e 38 to 571 1 to 532       532/580
(91 %)
7 diff
(98.8 %id)
CB148138 Liver .e 38 to 628 1 to 591       591/591
(100 %)
8 diff
(98.7 %id)
AF151085 umbilical cord blood .e 39 to 1180 1 to 1140 M49V S50I S51L C52S R53G ...     1140/1141
(99 %)
6 diff
(99.5 %id)
BE740486 adenocarcinoma cell line, ovary .e 40 to 714 1 to 674       674/683
(98 %)
4 diff
(99.5 %id)
BG701069 brain, hippocampus .e 42 to 776 1 to 739       739/739
(100 %)
15 diff
(98.0 %id)
BI550342 brain, hippocampus .e 42 to 709 1 to 684       682/718
(94 %)
39 diff
(94.6 %id)
BQ223160 embryonal carcinoma, cell line, testis .e 43 to 708 1 to 675       675/1197
(56 %)
19 diff
(98.5 %id)
BU177582 melanotic melanoma, skin .e 43 to 892 10 to 860 K221X A225G A226X K227X K228E ...     851/861
(98 %)
14 diff
(98.4 %id)
BE276325 melanotic melanoma, skin .e 45 to 706 1 to 656       656/710
(92 %)
17 diff
(97.7 %id)
BQ064051 lymph, lymphoma, cell line .e 45 to 846 1 to 801   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 801/803
(99 %)
5 diff
(99.4 %id)
BQ065269 lymph, lymphoma, cell line .e 45 to 834 1 to 790       790/790
(100 %)
7 diff
(99.2 %id)
BP369672 testis .e 46 to 612 1 to 567       567/567
(100 %)
2 diff
(99.7 %id)
BP369888 testis .e 46 to 614 1 to 569       569/569
(100 %)
1 diff
(99.9 %id)
BP371317 testis .e 46 to 631 1 to 582       582/582
(100 %)
8 diff
(98.7 %id)
AK001929 placenta .e 47 to 1595 1 to 1549 exact available from FLJ,   1549/1549
(100 %)
2 diff
(99.9 %id)
EC584851 Prostate .e 47 to 146 1 to 97       97/97
(100 %)
6 diff
(93.9 %id)
BP234581 coronary artery .e 47 to 649 1 to 603       603/603
(100 %)
1 diff
(99.9 %id)
BG111824 Bone, osteosarcoma, cell line .e 47 to 710 1 to 668       668/722
(92 %)
24 diff
(96.7 %id)
BG288180 bladder, transitional cell papilloma, cell line .e 47 to 813 17 to 784       768/830
(92 %)
26 diff
(96.9 %id)
BQ425965 melanotic melanoma, skin .e 47 to 883 1 to 841 K187X K192X K230E K232E K233E ...     841/842
(99 %)
8 diff
(99.1 %id)
BP272631   .e 47 to 564 1 to 517       517/561
(92 %)
28 diff
(95.1 %id)
BP303245   .e 47 to 628 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
AU128995   .e 47 to 544 2 to 497   capped   496/498
(99 %)
7 diff
(98.6 %id)
AU136705 placenta .e 47 to 548 2 to 505   capped   504/515
(97 %)
7 diff
(98.7 %id)
BM786278 Ascites, stomach .e 47 to 694 1 to 648       648/648
(100 %)
0 diff
(100 %id)
DN990458 brain, whole brain .e 47 to 764 8 to 724       717/724
(99 %)
7 diff
(99.1 %id)
AA375645 lung .e 48 to 321 1 to 273       273/273
(100 %)
3 diff
(99.0 %id)
DA486484 brain .e 48 to 601 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DA695440   .e 48 to 604 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
AW957688   .e 49 to 692 1 to 644       644/645
(99 %)
6 diff
(99.1 %id)
CN423134 embryonic stem cells, cell lines H1, H7, andH9 .e 50 to 587 1 to 538       538/538
(100 %)
2 diff
(99.7 %id)
BG501794 embryonal carcinoma, testis .e 50 to 714 1 to 664       664/669
(99 %)
10 diff
(98.6 %id)
EC452894 Prostate .e 51 to 153 1 to 102       102/102
(100 %)
3 diff
(97.1 %id)
AW239566 lung, cell line .e 51 to 454 1 to 404       404/404
(100 %)
3 diff
(99.3 %id)
DA367288 subthalamic nucleus .e 52 to 627 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
CD696034 normal nasopharynx .e 52 to 564 15 to 529       515/533
(96 %)
8 diff
(98.5 %id)
BP370556 testis .e 52 to 564 1 to 514       514/570
(90 %)
10 diff
(98.3 %id)
AV738446 cord Blood .e 55 to 308 38 to 354       317/355
(89 %)
11 diff
(97.0 %id)
DT218854 brain .e 56 to 700 1 to 645       645/645
(100 %)
0 diff
(100 %id)
BP369193 testis .e 56 to 621 1 to 566       566/566
(100 %)
2 diff
(99.7 %id)
DA004228   .e 57 to 614 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BC050609 Uterus, leiomyosarcoma .e 57 to 1611 1 to 1555 exact available from MGC, AAA   1555/1555
(100 %)
3 diff
(99.9 %id)
DA325180 hippocampus .e 57 to 578 2 to 524   capped   523/523
(100 %)
2 diff
(99.7 %id)
CD701922 normal nasopharynx .e 57 to 565 45 to 554       510/554
(92 %)
11 diff
(98.1 %id)
CX866947 embryonic stem .e 58 to 819 1 to 762       762/762
(100 %)
0 diff
(100 %id)
DB475781.
matches multiple genes
hippocampus .e 59 to 552 1 to 494     also hits gene FABP3 494/494
(100 %)
0 diff
(100 %id)
BM454966 leiomyosarcoma, uterus .e 59 to 972 28 to 952 K229E H235P K236Q H239P     925/954
(96 %)
26 diff
(97.3 %id)
BM906575 ovary (pool of 3) .e 59 to 720 1 to 666       666/1225
(54 %)
10 diff
(99.2 %id)
BU521192 leiomyosarcoma, uterus .e 59 to 882 1 to 836 T179X N181K P182S S183F R184*     836/853
(98 %)
14 diff
(98.4 %id)
BG033054 breast, mammary adenocarcinoma, cell line .e 60 to 714 1 to 651       651/879
(74 %)
10 diff
(98.9 %id)
CX870280 embryonic stem .e 60 to 845 1 to 786       786/786
(100 %)
0 diff
(100 %id)
BC007446 Muscle, rhabdomyosarcoma .e 61 to 1611 1 to 1551 exact available from MGC, AAA   1551/1551
(100 %)
1 diff
(100.0 %id)
BF568435 epithelioid carcinoma cell line, Pancreas .e 61 to 861 1 to 797       797/821
(97 %)
34 diff
(95.9 %id)
BE019100 muscle, rhabdomyosarcoma .e 62 to 569 1 to 508       508/508
(100 %)
0 diff
(100 %id)
BM698203 eye, fetal eyes .e 62 to 691 1 to 630       630/630
(100 %)
0 diff
(100 %id)
TI_149295180   .e 63 to 850 842 to 58       785/1032
(76 %)
6 diff
(99.5 %id)
BI859442 breast, mammary adenocarcinoma, cell line .e 64 to 848 1 to 791       791/791
(100 %)
21 diff
(97.4 %id)
TI_57190741   .e 64 to 848 56 to 846       791/791
(100 %)
21 diff
(97.4 %id)
BP222803   .e 65 to 647 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
CX871748 embryonic stem .e 65 to 819 1 to 755       755/755
(100 %)
0 diff
(100 %id)
CX865704 embryonic stem .e 66 to 840 1 to 775       775/775
(100 %)
0 diff
(100 %id)
BG282080 melanotic melanoma, skin .e 67 to 834 1 to 768       768/780
(98 %)
14 diff
(98.3 %id)
AF151077 umbilical cord blood .e 68 to 1617 1 to 1550 exact AAA   1550/1550
(100 %)
3 diff
(99.9 %id)
CN423135 embryonic stem cells, cell lines H1, H7, andH9 .e 68 to 728 1 to 661       661/661
(100 %)
0 diff
(100 %id)
CN423138 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 69 to 561 1 to 493       493/493
(100 %)
4 diff
(99.2 %id)
BQ439779 melanotic melanoma, skin .e 69 to 666 1 to 600       600/1064
(56 %)
5 diff
(99.6 %id)
BM985210 lung .e 70 to 840 771 to 3   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 769/777
(98 %)
0 diff
(100 %id)
AA417805 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 77 to 510 14 to 447   fully sequenced,   434/447
(97 %)
0 diff
(100 %id)
BM018041 astrocytoma grade IV, cell line, brain .e 77 to 467 2 to 398       397/1108
(35 %)
15 diff
(98.7 %id)
BQ939793 epidermoid carcinoma, cell line, lung .e 77 to 846 1 to 769   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 769/846
(90 %)
5 diff
(99.5 %id)
TI_59388623   .e 77 to 467 102 to 498       397/1107
(35 %)
15 diff
(98.7 %id)
BE378073 endometrium, adenocarcinoma cell line, uterus .e 79 to 674 1 to 602       600/878
(68 %)
8 diff
(99.1 %id)
BE779525 eye, retinoblastoma .e 79 to 720 1 to 634       634/929
(68 %)
22 diff
(97.7 %id)
DN993431 brain, whole brain .e 80 to 704 8 to 632       625/632
(98 %)
1 diff
(99.9 %id)
CA951055 Pancreas, Purified pancreatic islet .e 82 to 493 1 to 412   fully sequenced,   412/412
(100 %)
0 diff
(100 %id)
CX871707 embryonic stem .e 85 to 859 1 to 775       775/775
(100 %)
0 diff
(100 %id)
TI_57202517   .e 86 to 950 61 to 930 C146R K187Q K188E E189G K190E ...     870/930
(93 %)
40 diff
(95.7 %id)
BI823742 pooled brain, lung, testis .e 89 to 950 1 to 867 C146R K187Q K188E E189G K190E ...     867/867
(100 %)
34 diff
(96.1 %id)
CR594706 fetal liver .e 91 to 1599 1 to 1509 exact     1509/1509
(100 %)
0 diff
(100 %id)
CR599294 fetal brain .e 91 to 1608 1 to 1518 exact tiling clone,   1518/1518
(100 %)
0 diff
(100 %id)
CR614242 Placenta Cot 25-normalized .e 91 to 1599 1 to 1509 exact     1509/1509
(100 %)
0 diff
(100 %id)
BX440925 brain, fetal brain .e 91 to 959 1 to 865 E75X D97B R111A R112E S114R ... fully sequenced,   862/862
(100 %)
10 diff
(98.9 %id)
BX379075 Placenta Cot 25-normalized .e 91 to 650 1 to 560   fully sequenced,   560/560
(100 %)
0 diff
(100 %id)
BX358816 Placenta Cot 25-normalized .e 91 to 714 1 to 624       624/624
(100 %)
0 diff
(100 %id)
BX427422 fetal liver, Liver .e 91 to 961 1 to 863 E59V I60D V61S D62R V63C ... fully sequenced,   863/863
(100 %)
3 diff
(99.7 %id)
BE731091 choriocarcinoma, placenta .e 91 to 836 14 to 751       738/860
(85 %)
23 diff
(97.4 %id)
BI224030 cervical carcinoma cell line, cervix .e 91 to 714 17 to 651       635/665
(95 %)
25 diff
(96.3 %id)
BQ439355 epithelioid carcinoma, Pancreas .e 91 to 895 48 to 861 G64*     814/934
(87 %)
42 diff
(95.6 %id)
TI_154176619   .e 91 to 714 102 to 724       623/1165
(53 %)
23 diff
(98.1 %id)
BU624029 cell lines, Enchondroma .e 91 to 840 749 to 3   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 747/750
(99 %)
2 diff
(99.8 %id)
BE895545 melanotic melanoma, skin .e 93 to 704 1 to 619       619/975
(63 %)
15 diff
(98.5 %id)
BM552087 leiomyosarcoma, uterus .e 93 to 993 1 to 916 H235X K236X     872/1020
(85 %)
14 diff
(98.7 %id)
AA134649   .e 95 to 458 1 to 364       364/364
(100 %)
1 diff
(99.8 %id)
AA134623   .e 96 to 457 1 to 364       364/364
(100 %)
2 diff
(99.5 %id)
BP206088 coronary artery .e 98 to 666 1 to 570       570/570
(100 %)
2 diff
(99.7 %id)
CA431358 cell lines, Enchondroma .e 99 to 840 742 to 3   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 740/742
(99 %)
0 diff
(100 %id)
BF127731 leiomyosarcoma cell line, uterus .e 101 to 701 1 to 608       608/654
(92 %)
34 diff
(94.9 %id)
DA479272   .e 103 to 663 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
CA432772 mixed .e 103 to 352 11 to 260     Submitted on the opposite strand 250/250
(100 %)
3 diff
(98.8 %id)
DA365003 subthalamic nucleus .e 105 to 663 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
CD627971   .e 105 to 705 598 to 1       598/601
(99 %)
3 diff
(99.6 %id)
BE383240 brain, neuroblastoma .e 108 to 769 1 to 665       665/666
(99 %)
10 diff
(98.5 %id)
BQ445843 Knee, Osteoarthritic Cartilage .e 109 to 840 732 to 2   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 731/732
(99 %)
0 diff
(100 %id)
CD685477 normal nasopharynx .e 123 to 628 19 to 524       506/524
(96 %)
7 diff
(98.7 %id)
BU521145 leiomyosarcoma, uterus .e 123 to 710 1 to 589       589/601
(98 %)
5 diff
(99.2 %id)
CV569717 cornea, eye .e 126 to 728 1 to 603       603/603
(100 %)
0 diff
(100 %id)
TI_1948101135   .e 133 to 493 111 to 471   fully sequenced,   361/471
(76 %)
6 diff
(98.8 %id)
TI_1948100990   .e 136 to 870 117 to 853       737/1380
(53 %)
37 diff
(97.4 %id)
BQ945790 epidermoid carcinoma, cell line, lung .e 137 to 828 1 to 693       693/942
(73 %)
3 diff
(99.7 %id)
BP289732 lung .e 140 to 720 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BP369308 testis .e 140 to 719 1 to 580       580/581
(99 %)
11 diff
(98.2 %id)
BG121112 adenocarcinoma, cell line, Liver .e 144 to 914 1 to 775 C146G P178L T179Q R180G K192N ...     775/814
(95 %)
34 diff
(95.9 %id)
CV026629 mixed .e 146 to 704 1 to 559       559/593
(94 %)
2 diff
(99.7 %id)
TI_1948101418   .e 146 to 715 133 to 704       572/1435
(39 %)
36 diff
(97.5 %id)
AW005427 anaplastic oligodendroglioma, brain .e 197 to 829 634 to 1       634/634
(100 %)
3 diff
(99.6 %id)
BM793015 Ascites, stomach .e 202 to 716 1 to 515       515/515
(100 %)
0 diff
(100 %id)
CA950803 Pancreas, Purified pancreatic islet .e 432 to 828 397 to 1   fully sequenced,   397/397
(100 %)
0 diff
(100 %id)
TI_1948101136   .e 432 to 870 560 to 122   fully sequenced,   439/560
(78 %)
0 diff
(100 %id)
AA417806 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 480 to 822 343 to 1   fully sequenced,   343/343
(100 %)
0 diff
(100 %id)
BX379074 Placenta Cot 25-normalized .e 620 to 1599 978 to 1   fully sequenced,   978/978
(100 %)
6 diff
(99.4 %id)
BX358815 Placenta Cot 25-normalized .e 798 to 1524 778 to 50       729/778
(93 %)
0 diff
(100 %id)
BQ058013 lymph, lymphoma, cell line .e 853 to 1850 1 to 1012       1012/1021
(99 %)
36 diff
(96.5 %id)
BX353204 Neuroblastoma Cot 25-normalized .e 881 to 1553 692 to 19   fully sequenced,   674/674
(100 %)
27 diff
(96.0 %id)
BX375307 Neuroblastoma Cot 25-normalized .e 896 to 1558 665 to 1       665/850
(78 %)
0 diff
(100 %id)
BX454981 brain, fetal brain .e 929 to 1606 675 to 1   fully sequenced,   675/675
(100 %)
9 diff
(98.7 %id)
BX427421 fetal liver, Liver .e 931 to 1599 671 to 1   fully sequenced,   671/671
(100 %)
9 diff
(98.7 %id)
CX865624 embryonic stem .e 982 to 1611 657 to 28   AAA   630/630
(100 %)
3 diff
(99.6 %id)
AA007339 liver and spleen .e 1005 to 1483 1 to 478       478/479
(99 %)
4 diff
(99.2 %id)
BU735995 eye, fetal eyes .e 1020 to 1611 610 to 19   AAA   592/592
(100 %)
1 diff
(99.9 %id)
AA167731   .e 1033 to 1614 582 to 4       579/582
(99 %)
0 diff
(100 %id)
BE207840 muscle, rhabdomyosarcoma .e 1149 to 1614 470 to 5       466/470
(99 %)
0 diff
(100 %id)
AU151195   .e 1170 to 1611 442 to 1       442/447
(98 %)
1 diff
(99.8 %id)
AU156829 placenta .e 1237 to 1595 357 to 1       357/368
(97 %)
11 diff
(97.1 %id)
TI_154020567   .e 1529 to 2189 763 to 102   AAA   662/662
(100 %)
3 diff
(99.6 %id)
CA438523 lung, Metastatic Chondrosarcoma .e 1577 to 2189 629 to 16   tiling clone, AAA   614/614
(100 %)
1 diff
(99.9 %id)
AA417204   .e 1658 to 1953 1 to 295   fully sequenced,   295/295
(100 %)
1 diff
(99.7 %id)
AI827958 anaplastic oligodendroglioma, brain .e 1779 to 2382 605 to 1       605/605
(100 %)
1 diff
(99.9 %id)
AA007340 liver and spleen .e 1919 to 2382 466 to 1       466/466
(100 %)
5 diff
(99.0 %id)
AA417100   .e 1923 to 2385 461 to 1   fully sequenced,   461/461
(100 %)
0 diff
(100 %id)
AI494244 anaplastic oligodendroglioma, brain .e 1931 to 2382 452 to 1       452/452
(100 %)
0 diff
(100 %id)
BX490938   .e 1998 to 2549 1 to 554   tiling clone,   554/554
(100 %)
6 diff
(99.0 %id)
AI299616 carcinoid, lung .e 2024 to 2381 358 to 1       358/358
(100 %)
0 diff
(100 %id)
DA806887 brain .e 2160 to 2724 2 to 568   tiling clone, capped   567/567
(100 %)
1 diff
(99.9 %id)
BM311885 Pancreas, Purified pancreatic islet .f 1 to 558 10 to 567   tiling clone,   559/567
(98 %)
6 diff
(99.0 %id)
BP370297 testis .f 7 to 574 1 to 568       568/568
(100 %)
10 diff
(98.3 %id)
BP201461 amygdala .f 21 to 601 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BQ441234 testis .f 22 to 819 1 to 807       810/808
(100 %)
34 diff
(95.8 %id)
AW631025 2 pooled high-grade transitional celltumors, genitourinary tract .f 23 to 432 10 to 419       410/441
(92 %)
17 diff
(96.2 %id)
BF791078 muscle (skeletal) .f 23 to 621 1 to 601       601/884
(67 %)
19 diff
(97.9 %id)
BX375900 Neuroblastoma Cot 25-normalized .f 24 to 771 1 to 748       748/748
(100 %)
5 diff
(99.4 %id)
BI561158 testis .f 25 to 757 7 to 739       733/743
(98 %)
12 diff
(98.4 %id)
TI_44348837   .f 25 to 757 88 to 820       733/824
(88 %)
12 diff
(98.6 %id)
AK302248 testis .f 34 to 993 1 to 960 exact     960/960
(100 %)
1 diff
(99.9 %id)
DC398813 testis .f 34 to 604 1 to 572       572/572
(100 %)
2 diff
(99.7 %id)
BP355726   .f 38 to 620 1 to 589       589/589
(100 %)
12 diff
(98.0 %id)
CR592026 Neuroblastoma Cot 25-normalized .f 48 to 1638 1 to 1591 exact tiling clone,   1591/1591
(100 %)
0 diff
(100 %id)
BX376157 Neuroblastoma Cot 25-normalized .f 48 to 834 1 to 776   fully sequenced,   776/776
(100 %)
0 diff
(100 %id)
BQ213597 melanotic melanoma, skin .f 48 to 892 24 to 881       858/894
(95 %)
38 diff
(95.8 %id)
CN423136 embryonic stem cells, cell lines H1, H7, andH9 .f 49 to 684 1 to 635       635/635
(100 %)
1 diff
(99.9 %id)
BM909581 lymph, lymphoma, cell line .f 49 to 875 1 to 829       829/1076
(77 %)
9 diff
(99.2 %id)
EB386094 eye, optic nerve .f 50 to 760 1 to 711       711/711
(100 %)
1 diff
(99.9 %id)
BE890761 melanotic melanoma, skin .f 66 to 760 1 to 693       693/939
(73 %)
16 diff
(98.3 %id)
BE732270 choriocarcinoma, placenta .f 104 to 767 23 to 704       679/706
(96 %)
38 diff
(94.7 %id)
BM311294 Pancreas, Purified pancreatic islet .f 249 to 771 523 to 1       523/523
(100 %)
0 diff
(100 %id)
BX375899 Neuroblastoma Cot 25-normalized .f 765 to 1634 869 to 1       869/869
(100 %)
8 diff
(99.1 %id)
BX376156 Neuroblastoma Cot 25-normalized .f 804 to 1638 835 to 1   fully sequenced,   835/835
(100 %)
11 diff
(98.7 %id)
DC366453   .g 1 to 584 1 to 584   tiling clone,   584/584
(100 %)
1 diff
(99.9 %id)
BU195787 leiomyosarcoma, uterus .g 27 to 839 1 to 815       815/819
(99 %)
11 diff
(98.7 %id)
DC376557 brain .g 51 to 535 1 to 484       484/484
(100 %)
1 diff
(99.8 %id)
DC353524 brain .g 68 to 581 1 to 517       517/517
(100 %)
12 diff
(97.7 %id)
DC339393 subthalamic nucleus .g 79 to 534 1 to 456       456/456
(100 %)
0 diff
(100 %id)
BM795059 Ascites, stomach .g 81 to 347 1 to 267       267/267
(100 %)
18 diff
(93.3 %id)
BP194245 brain .g 83 to 664 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DC380399 placenta .g 83 to 655 1 to 573       573/573
(100 %)
0 diff
(100 %id)
DC396068 testis .g 85 to 629 1 to 546       546/546
(100 %)
2 diff
(99.7 %id)
BP218000 caudate nucleus .g 93 to 669 1 to 578       578/583
(99 %)
17 diff
(97.1 %id)
BG421887 Kidney, renal cell adenocarcinoma .g 100 to 816 1 to 712       712/947
(75 %)
17 diff
(98.3 %id)
BC000685 Kidney, renal cell adenocarcinoma .g 101 to 988 1 to 887 exact tiling clone, available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 887/889
(99 %)
6 diff
(99.4 %id)
BE896028 melanotic melanoma, skin .g 115 to 819 1 to 703   AAA   701/832
(84 %)
13 diff
(98.5 %id)
BE272615 Kidney, renal cell adenocarcinoma .g 120 to 707 1 to 588   available from MGC,   588/588
(100 %)
0 diff
(100 %id)
CV805881 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .g 133 to 935 1 to 803       803/804
(99 %)
3 diff
(99.7 %id)
AW385766 leiomios .g 206 to 699 147 to 640       494/640
(77 %)
10 diff
(98.5 %id)
AK307478 thalamus .h 1 to 1491 1 to 1488 I48G G49R R50E E51M M52K ... tiling clone,   1488/1488
(100 %)
6 diff
(99.6 %id)
DA376164 thalamus .h 2 to 564 2 to 561   capped   560/560
(100 %)
4 diff
(99.3 %id)
DC418090 trachea .h 2 to 404 1 to 403       403/403
(100 %)
0 diff
(100 %id)
FN138177 breast carcinoma .h 64 to 165 1 to 103       103/103
(100 %)
6 diff
(94.2 %id)
CB131835 Liver .h 66 to 554 1 to 490       490/490
(100 %)
5 diff
(99.0 %id)
BF869131 lung_tumor .h 70 to 418 9 to 357       349/363
(96 %)
8 diff
(97.8 %id)
AI424382 Prostate .h 72 to 689 618 to 1       618/639
(96 %)
2 diff
(99.7 %id)
BE858870 Prostate .h 87 to 678 603 to 12       592/603
(98 %)
7 diff
(98.9 %id)
BF700704 brain, primitive neuroectoderm .h 89 to 691 1 to 609       609/882
(69 %)
26 diff
(97.1 %id)
EC479584 Prostate .h 91 to 178 14 to 100       87/100
(87 %)
8 diff
(92.0 %id)
EC479549 Prostate .h 101 to 195 1 to 94       94/97
(96 %)
6 diff
(93.9 %id)
EC551891 Prostate .h 102 to 199 1 to 98       98/98
(100 %)
2 diff
(98.0 %id)
BI160080 epithelioid carcinoma cell line, Pancreas .h 103 to 715 1 to 621       621/624
(99 %)
19 diff
(97.0 %id)
DR762005 embryonic stem .h 106 to 764 3 to 659   tiling clone,   657/659
(99 %)
6 diff
(99.1 %id)
BX089478 lung .h 120 to 765 1 to 647       647/647
(100 %)
1 diff
(99.9 %id)
BE857122 brain, glioblastoma (pooled) .h 120 to 682 563 to 1       563/563
(100 %)
0 diff
(100 %id)
AV736638 cord Blood .h 128 to 697 30 to 586   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 561/588
(95 %)
25 diff
(95.8 %id)
EC555844 Prostate .h 128 to 215 16 to 106       91/108
(84 %)
4 diff
(96.3 %id)
AI422747 brain, glioblastoma (pooled) .h 128 to 682 555 to 1       555/560
(99 %)
1 diff
(99.9 %id)
BM790165 stomach .h 128 to 403 21 to 296       276/296
(93 %)
18 diff
(94.0 %id)
AA670283 whole brain .h 129 to 682 554 to 1       554/557
(99 %)
0 diff
(100 %id)
BF436769 Prostate .h 132 to 691 560 to 1       560/560
(100 %)
0 diff
(100 %id)
BQ308740 breast .h 139 to 727 591 to 3       589/591
(99 %)
0 diff
(100 %id)
CD643969 Embryonic Stem cells .h 152 to 714 571 to 9     Submitted on the opposite strand 563/571
(98 %)
2 diff
(99.7 %id)
CD655247 Embryonic Stem cells .h 152 to 686 547 to 12     Submitted on the opposite strand 536/547
(97 %)
2 diff
(99.7 %id)
BU588592 mixed (pool of 40 RNAs) .h 168 to 424 1 to 257       257/297
(86 %)
2 diff
(99.4 %id)
EC525702 Prostate .h 177 to 277 1 to 100       100/100
(100 %)
1 diff
(99.0 %id)
EC478314 Prostate .h 181 to 286 1 to 106       106/106
(100 %)
6 diff
(94.4 %id)
EC497813 Prostate .h 191 to 297 1 to 106       106/106
(100 %)
10 diff
(90.6 %id)
EL953201 eyeball .h 192 to 754 38 to 596       559/596
(93 %)
16 diff
(97.4 %id)
BP251700 hippocampus .h 194 to 776 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
BP319350 pericardium .h 198 to 779 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DN601914 human embryonic stem cells .h 203 to 885 1 to 684       684/684
(100 %)
1 diff
(99.9 %id)
EC463091 Prostate .h 217 to 318 1 to 101       101/101
(100 %)
1 diff
(99.1 %id)
TI_154037281   .h 221 to 710 546 to 57       490/853
(57 %)
0 diff
(100 %id)
CA444410 lung, Metastatic Chondrosarcoma .h 221 to 703 484 to 2   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 483/502
(96 %)
0 diff
(100 %id)
CD556573 brain, Pituitary .h 229 to 1070 42 to 892       851/893
(95 %)
32 diff
(96.5 %id)
CB242594 Human Lung Epithelial cells, lung .h 229 to 697 469 to 3   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 467/560
(83 %)
0 diff
(100 %id)
EC528183 Prostate .h 257 to 359 1 to 103       103/103
(100 %)
0 diff
(100 %id)
EC535526 Prostate .h 258 to 348 4 to 90       87/98
(88 %)
9 diff
(90.9 %id)
EC443220 Prostate .h 259 to 364 5 to 111       107/111
(96 %)
6 diff
(94.6 %id)
AI908445 breast .h 263 to 734 475 to 4       472/475
(99 %)
0 diff
(100 %id)
EC491336 Prostate .h 267 to 365 1 to 99       99/99
(100 %)
2 diff
(98.0 %id)
EC580202 Prostate .h 270 to 366 7 to 102       96/102
(94 %)
6 diff
(94.2 %id)
CB129574 Liver .h 274 to 637 1 to 365       365/365
(100 %)
8 diff
(97.9 %id)
EC543815 Prostate .h 275 to 377 1 to 104       104/104
(100 %)
3 diff
(97.2 %id)
BM551239 amelanotic melanoma, cell line, skin .h 276 to 899 34 to 663       630/1139
(55 %)
19 diff
(98.4 %id)
AI079202 brain, glioblastoma (pooled) .h 292 to 687 396 to 1       396/396
(100 %)
0 diff
(100 %id)
EC543068 Prostate .h 299 to 388 1 to 89       89/89
(100 %)
4 diff
(95.6 %id)
EC493558 Prostate .h 301 to 401 1 to 101       101/101
(100 %)
2 diff
(98.1 %id)
FN173392 breast carcinoma .h 307 to 387 1 to 81       81/96
(84 %)
2 diff
(98.0 %id)
EC543425 Prostate .h 322 to 424 1 to 103       103/105
(98 %)
3 diff
(97.2 %id)
EC501793 Prostate .h 323 to 412 11 to 100       90/100
(90 %)
6 diff
(94.0 %id)
AA872297 2 pooled tumors (clear cell type), Kidney .h 323 to 685 362 to 1       362/371
(97 %)
1 diff
(99.8 %id)
BG492431 lung, mucoepidermoid carcinoma .h 337 to 1010 1 to 674       674/676
(99 %)
9 diff
(98.7 %id)
BG493163 lung, mucoepidermoid carcinoma .h 337 to 943 1 to 607       607/607
(100 %)
3 diff
(99.6 %id)
EC544702 Prostate .h 340 to 435 1 to 96       96/96
(100 %)
0 diff
(100 %id)
FN118772 breast carcinoma .h 345 to 422 1 to 78       78/79
(98 %)
1 diff
(98.8 %id)
AW250995 lung, small cell carcinoma .h 347 to 697 353 to 3   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 351/353
(99 %)
8 diff
(97.8 %id)
EC477711 Prostate .h 355 to 454 1 to 100       100/100
(100 %)
0 diff
(100 %id)
EC571934 Prostate .h 357 to 457 1 to 101       101/101
(100 %)
0 diff
(100 %id)
EC441727 Prostate .h 360 to 460 1 to 101       101/101
(100 %)
3 diff
(97.1 %id)
EC558254 Prostate .h 361 to 460 1 to 99       99/99
(100 %)
1 diff
(99.0 %id)
EC492934 Prostate .h 366 to 467 1 to 102       102/102
(100 %)
0 diff
(100 %id)
CD358202 testis .h 369 to 1178 1 to 816       816/920
(88 %)
27 diff
(97.1 %id)
AI199470 anaplastic oligodendroglioma, brain .h 377 to 692 320 to 6       315/320
(98 %)
1 diff
(99.7 %id)
BU155250 melanotic melanoma, cell line, skin .h 384 to 1224 19 to 867       849/934
(90 %)
27 diff
(97.2 %id)
BQ683239 melanotic melanoma, cell line, skin .h 384 to 1308 19 to 949       931/967
(96 %)
50 diff
(94.9 %id)
EC506679 Prostate .h 387 to 484 1 to 98       98/98
(100 %)
3 diff
(97.0 %id)
EC570082 Prostate .h 392 to 495 1 to 101       101/101
(100 %)
5 diff
(95.1 %id)
EC466912.
matches multiple genes
Prostate .h 393 to 490 1 to 98   tiling clone, also hits gene luskawby 98/102
(96 %)
4 diff
(96.1 %id)
EC557457 Prostate .h 398 to 495 9 to 106       98/106
(92 %)
0 diff
(100 %id)
EC553211 Prostate .h 400 to 484 13 to 97       85/97
(87 %)
6 diff
(93.9 %id)
EC565447 Prostate .h 405 to 512 1 to 108       108/108
(100 %)
1 diff
(99.1 %id)
EC476700 Prostate .h 406 to 512 1 to 107       107/107
(100 %)
0 diff
(100 %id)
BF932790 nervous_tumor .h 408 to 881 1 to 473       473/473
(100 %)
6 diff
(98.8 %id)
EC580121 Prostate .h 412 to 517 1 to 107       107/107
(100 %)
2 diff
(98.2 %id)
EC447439 Prostate .h 413 to 517 1 to 105       105/105
(100 %)
0 diff
(100 %id)
EC534818 Prostate .h 413 to 517 1 to 103       103/103
(100 %)
2 diff
(98.1 %id)
EC521709 Prostate .h 414 to 517 1 to 102       102/102
(100 %)
2 diff
(98.1 %id)
EC454933 Prostate .h 418 to 523 1 to 106       106/106
(100 %)
0 diff
(100 %id)
EC476539 Prostate .h 422 to 517 9 to 104       96/104
(92 %)
6 diff
(94.3 %id)
EC470076 Prostate .h 424 to 523 1 to 98       98/101
(97 %)
3 diff
(97.1 %id)
EC508563 Prostate .h 427 to 530 1 to 104       104/104
(100 %)
0 diff
(100 %id)
EC463937 Prostate .h 429 to 532 1 to 102       102/102
(100 %)
6 diff
(94.2 %id)
EC464546 Prostate .h 429 to 532 1 to 104       104/104
(100 %)
2 diff
(98.1 %id)
EC464906 Prostate .h 429 to 532 1 to 99       99/99
(100 %)
6 diff
(94.0 %id)
EC550170 Prostate .h 429 to 532 1 to 99       99/99
(100 %)
7 diff
(93.0 %id)
EC537784 Prostate .h 431 to 532 1 to 105       105/105
(100 %)
7 diff
(93.4 %id)
EC462229 Prostate .h 444 to 547 1 to 102       102/102
(100 %)
2 diff
(98.1 %id)
EC462632 Prostate .h 444 to 547 1 to 103       103/103
(100 %)
1 diff
(99.1 %id)
EC487370 Prostate .h 444 to 547 1 to 104       104/104
(100 %)
2 diff
(98.1 %id)
EC550410 Prostate .h 444 to 546 1 to 101       101/101
(100 %)
2 diff
(98.1 %id)
EC443586 Prostate .h 445 to 546 1 to 102       102/102
(100 %)
2 diff
(98.1 %id)
EC516143 Prostate .h 445 to 546 1 to 98       98/98
(100 %)
6 diff
(93.9 %id)
EB361136 eye, lens .h 447 to 546 97 to 1       97/98
(98 %)
3 diff
(97.0 %id)
EC470659 Prostate .h 449 to 546 10 to 105       96/105
(91 %)
2 diff
(98.1 %id)
EC447975 Prostate .h 451 to 562 1 to 111       111/111
(100 %)
4 diff
(96.4 %id)
EC521147 Prostate .h 451 to 562 1 to 111       111/111
(100 %)
4 diff
(96.4 %id)
EC535446 Prostate .h 451 to 562 1 to 112       112/112
(100 %)
5 diff
(95.6 %id)
GD160429   .h 452 to 706 6 to 262   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 257/263
(97 %)
15 diff
(94.3 %id)
EC497644 Prostate .h 465 to 574 1 to 105       105/106
(99 %)
7 diff
(93.4 %id)
BQ310264 breast .h 466 to 999 1 to 535       535/601
(89 %)
43 diff
(92.9 %id)
EC457745 Prostate .h 468 to 574 1 to 106       106/113
(93 %)
7 diff
(93.9 %id)
BQ306398 breast .h 470 to 1019 1 to 549       549/549
(100 %)
7 diff
(98.8 %id)
EC492366 Prostate .h 470 to 574 1 to 102       102/106
(96 %)
5 diff
(95.3 %id)
EC535907 Prostate .h 471 to 574 1 to 98       98/108
(90 %)
8 diff
(92.6 %id)
BQ306370 breast .h 472 to 1087 8 to 617       610/644
(94 %)
19 diff
(97.1 %id)
BQ306875 breast .h 472 to 1068 1 to 599       599/602
(99 %)
6 diff
(99.1 %id)
EC499693 Prostate .h 475 to 574 1 to 100       100/117
(85 %)
4 diff
(96.6 %id)
BQ306915 breast .h 477 to 1066 1 to 585       585/585
(100 %)
9 diff
(98.5 %id)
EC558559 Prostate .h 477 to 574 1 to 97       97/114
(85 %)
3 diff
(97.4 %id)
BQ306916 breast .h 478 to 1092 1 to 615       615/615
(100 %)
5 diff
(99.2 %id)
EC514328 Prostate .h 479 to 574 11 to 105       95/112
(84 %)
6 diff
(94.7 %id)
EC501498 Prostate .h 480 to 574 1 to 94       94/108
(87 %)
3 diff
(97.3 %id)
EC505838 Prostate .h 481 to 574 1 to 91       91/105
(86 %)
5 diff
(95.3 %id)
EC511369 Prostate .h 481 to 574 1 to 93       93/109
(85 %)
5 diff
(95.5 %id)
EC521292 Prostate .h 481 to 574 1 to 90       90/104
(86 %)
6 diff
(94.3 %id)
AI368541 anaplastic oligodendroglioma, brain .h 481 to 689 209 to 1       209/209
(100 %)
0 diff
(100 %id)
CA944813 Human Lung Epithelial cells, lung .h 482 to 706 39 to 262   AAA Submitted on the opposite strand 224/261
(85 %)
19 diff
(92.8 %id)
BQ306313 breast .h 483 to 650 175 to 8       168/175
(96 %)
0 diff
(100 %id)
TI_149277217   .h 484 to 1023 99 to 638     Submitted on the opposite strand 540/823
(65 %)
19 diff
(97.7 %id)
BM968077 lung, Primary Lung Epithelial Cells .h 484 to 1023 30 to 569     Submitted on the opposite strand 540/570
(94 %)
19 diff
(96.7 %id)
EC463820 Prostate .h 489 to 605 1 to 117       117/117
(100 %)
1 diff
(99.2 %id)
EC530705 Prostate .h 489 to 607 1 to 119       119/119
(100 %)
2 diff
(98.4 %id)
EC491779 Prostate .h 490 to 605 1 to 114       114/114
(100 %)
2 diff
(98.3 %id)
EC580468 Prostate .h 490 to 605 1 to 115       115/115
(100 %)
1 diff
(99.2 %id)
EC464018 Prostate .h 492 to 601 1 to 113       113/116
(97 %)
12 diff
(89.7 %id)
EC559017 Prostate .h 492 to 607 1 to 116       116/116
(100 %)
0 diff
(100 %id)
EC478554 Prostate .h 495 to 601 1 to 109       109/112
(97 %)
18 diff
(84.0 %id)
EC458306 Prostate .h 496 to 610 1 to 115       115/115
(100 %)
2 diff
(98.3 %id)
EC562492 Prostate .h 500 to 607 1 to 107       107/107
(100 %)
1 diff
(99.1 %id)
BQ307178 breast .h 502 to 1104 608 to 6       603/617
(97 %)
2 diff
(99.7 %id)
EC546145 Prostate .h 503 to 607 9 to 111       100/111
(90 %)
8 diff
(92.8 %id)
EC563943 Prostate .h 504 to 611 1 to 106       106/106
(100 %)
2 diff
(98.2 %id)
EC513266 Prostate .h 506 to 613 1 to 109       109/109
(100 %)
1 diff
(99.1 %id)
BQ306307 breast .h 507 to 1104 609 to 6       604/609
(99 %)
2 diff
(99.7 %id)
BQ306392 breast .h 507 to 1104 598 to 5       594/600
(99 %)
5 diff
(99.2 %id)
BQ306324 breast .h 510 to 1100 591 to 4       588/592
(99 %)
3 diff
(99.5 %id)
CN423133 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .h 515 to 1031 1 to 517       517/517
(100 %)
1 diff
(99.9 %id)
EC571535 Prostate .h 517 to 622 1 to 106       106/106
(100 %)
0 diff
(100 %id)
EC579256 Prostate .h 520 to 620 1 to 99       99/99
(100 %)
2 diff
(98.0 %id)
EC577099 Prostate .h 522 to 616 25 to 115       91/107
(85 %)
8 diff
(92.6 %id)
EC576839 Prostate .h 525 to 620 1 to 94       94/94
(100 %)
8 diff
(91.5 %id)
EC462038 Prostate .h 530 to 628 1 to 97       97/97
(100 %)
2 diff
(98.0 %id)
EC516444 Prostate .h 530 to 628 1 to 99       99/99
(100 %)
0 diff
(100 %id)
EC500532 Prostate .h 531 to 631 1 to 101       101/101
(100 %)
3 diff
(97.1 %id)
EC561888 Prostate .h 531 to 628 1 to 97       97/97
(100 %)
1 diff
(99.0 %id)
EC440063 Prostate .h 533 to 630 1 to 98       98/98
(100 %)
2 diff
(98.0 %id)
EC486631 Prostate .h 535 to 631 15 to 105       91/105
(86 %)
8 diff
(92.4 %id)
EC522520 Prostate .h 538 to 630 1 to 89       89/89
(100 %)
10 diff
(88.8 %id)
EC537039 Prostate .h 539 to 640 1 to 100       100/100
(100 %)
2 diff
(98.0 %id)
BQ375364 testis_normal .h 541 to 891 368 to 21       348/382
(91 %)
0 diff
(100 %id)
EC469931 Prostate .h 541 to 640 1 to 98       98/98
(100 %)
2 diff
(98.0 %id)
EC490014 Prostate .h 543 to 633 1 to 90       90/90
(100 %)
9 diff
(90.0 %id)
BU941505 mixed (pool of 40 RNAs) .h 545 to 1318 1 to 786       786/786
(100 %)
18 diff
(97.8 %id)
EC485492 Prostate .h 548 to 643 15 to 107       93/107
(86 %)
7 diff
(93.5 %id)
AA350560 brain .h 554 to 914 1 to 362       362/362
(100 %)
1 diff
(99.8 %id)
AA350561 brain .h 554 to 957 1 to 404       404/404
(100 %)
0 diff
(100 %id)
EC556609 Prostate .h 558 to 656 1 to 99       99/99
(100 %)
0 diff
(100 %id)
BQ306379 breast .h 568 to 1104 541 to 5       537/560
(95 %)
0 diff
(100 %id)
BQ375355 testis_normal .h 568 to 898 14 to 343       330/343
(96 %)
9 diff
(97.4 %id)
EC455411 Prostate .h 568 to 656 12 to 99       88/99
(88 %)
6 diff
(94.0 %id)
EC478132 Prostate .h 568 to 652 6 to 90       85/90
(94 %)
6 diff
(93.4 %id)
EC530820 Prostate .h 568 to 628 48 to 108       61/108
(56 %)
0 diff
(100 %id)
EC556413 Prostate .h 568 to 650 14 to 95       82/95
(86 %)
6 diff
(93.7 %id)
EC571941 Prostate .h 568 to 656 11 to 98       88/98
(89 %)
6 diff
(93.9 %id)
FN087020 breast carcinoma .h 568 to 641 12 to 83       72/84
(85 %)
3 diff
(96.5 %id)
CF132181 Chondrosarcoma Lung Metastasis cell lines, lung .h 569 to 1257 63 to 751       689/751
(91 %)
6 diff
(99.3 %id)
TI_159677923   .h 569 to 1472 113 to 1001   AAA   889/952
(93 %)
6 diff
(99.4 %id)
EC448418 Prostate .h 570 to 661 1 to 91       91/91
(100 %)
1 diff
(99.0 %id)
EC465759 Prostate .h 570 to 661 1 to 92       92/92
(100 %)
2 diff
(97.9 %id)
EC580486 Prostate .h 572 to 662 1 to 90       90/93
(96 %)
2 diff
(97.9 %id)
EC456945 Prostate .h 574 to 662 1 to 89       89/91
(97 %)
1 diff
(99.0 %id)
EC530514 Prostate .h 574 to 662 1 to 89       89/91
(97 %)
1 diff
(99.0 %id)
EC549345 Prostate .h 574 to 662 1 to 85       85/88
(96 %)
5 diff
(94.4 %id)
EC440488 Prostate .h 576 to 662 7 to 93       87/95
(91 %)
1 diff
(99.0 %id)
EC443973 Prostate .h 576 to 662 1 to 88       88/90
(97 %)
2 diff
(97.8 %id)
EC463787 Prostate .h 576 to 662 1 to 87       87/92
(94 %)
1 diff
(99.0 %id)
EC463860 Prostate .h 576 to 662 1 to 86       86/90
(95 %)
2 diff
(97.8 %id)
EC535208 Prostate .h 576 to 652 14 to 89       76/89
(85 %)
6 diff
(93.3 %id)
EC545557 Prostate .h 576 to 662 1 to 86       86/90
(95 %)
2 diff
(97.8 %id)
EC549183 Prostate .h 576 to 650 16 to 90       75/91
(82 %)
4 diff
(95.7 %id)
EC579665 Prostate .h 576 to 662 1 to 87       87/92
(94 %)
2 diff
(97.9 %id)
BF760412 colon .h 577 to 951 1 to 372       372/374
(99 %)
8 diff
(97.9 %id)
EC476852 Prostate .h 577 to 662 1 to 86       86/91
(94 %)
1 diff
(99.0 %id)
EC544114 Prostate .h 577 to 662 1 to 87       87/89
(97 %)
3 diff
(96.7 %id)
EC448323 Prostate .h 578 to 662 1 to 86       86/91
(94 %)
4 diff
(95.7 %id)
EC506781 Prostate .h 578 to 662 1 to 85       85/90
(94 %)
1 diff
(98.9 %id)
EC572352 Prostate .h 578 to 662 1 to 85       85/94
(90 %)
1 diff
(99.0 %id)
EC563242 Prostate .h 579 to 669 1 to 89       89/90
(98 %)
7 diff
(92.3 %id)
EC454470 Prostate .h 580 to 666 1 to 86       86/89
(96 %)
5 diff
(94.4 %id)
EC490462 Prostate .h 580 to 662 1 to 85       85/94
(90 %)
5 diff
(94.7 %id)
EC525124 Prostate .h 580 to 669 1 to 90       90/91
(98 %)
5 diff
(94.6 %id)
EC529166 Prostate .h 580 to 662 1 to 83       83/92
(90 %)
1 diff
(99.0 %id)
EC484691 Prostate .h 581 to 662 1 to 82       82/91
(90 %)
1 diff
(99.0 %id)
EC485495 Prostate .h 581 to 662 1 to 82       82/91
(90 %)
1 diff
(99.0 %id)
EC538685 Prostate .h 581 to 662 1 to 82       82/91
(90 %)
1 diff
(99.0 %id)
EC582415 Prostate .h 581 to 662 1 to 82       82/91
(90 %)
1 diff
(99.0 %id)
EC448133 Prostate .h 586 to 662 1 to 76       76/85
(89 %)
4 diff
(95.3 %id)
EC552749 Prostate .h 587 to 662 1 to 75       75/84
(89 %)
2 diff
(97.7 %id)
EC562057 Prostate .h 587 to 662 1 to 76       76/85
(89 %)
1 diff
(98.9 %id)
EC491091 Prostate .h 588 to 669 1 to 81       81/82
(98 %)
6 diff
(92.7 %id)
EC571870 Prostate .h 588 to 662 1 to 75       75/84
(89 %)
1 diff
(98.9 %id)
BX370164 Placenta Cot 25-normalized .h 589 to 1283 1 to 697       697/874
(79 %)
38 diff
(95.7 %id)
EC527549 Prostate .h 592 to 662 1 to 71       71/80
(88 %)
1 diff
(98.8 %id)
EC511460 Prostate .h 593 to 662 2 to 70       69/79
(87 %)
3 diff
(96.3 %id)
FN094939 breast carcinoma .h 593 to 673 1 to 81       81/81
(100 %)
7 diff
(91.4 %id)
BP263663 small intestine .h 597 to 1177 1 to 581       581/581
(100 %)
4 diff
(99.4 %id)
TI_154110316   .h 601 to 1471 922 to 63   AAA   860/953
(90 %)
17 diff
(98.3 %id)
W40174 lung .h 604 to 1031 1 to 432   fully sequenced,   432/432
(100 %)
5 diff
(98.9 %id)
TI_57191123   .h 607 to 1072 84 to 549       466/469
(99 %)
1 diff
(99.8 %id)
BI857933 breast, mammary adenocarcinoma, cell line .h 608 to 1072 1 to 465       465/468
(99 %)
1 diff
(99.8 %id)
BM821670 stomach .h 625 to 1185 1 to 561       561/561
(100 %)
3 diff
(99.5 %id)
BX392976 Placenta Cot 25-normalized .h 626 to 1460 839 to 7       833/839
(99 %)
0 diff
(100 %id)
BM848866 stomach .h 626 to 1271 1 to 646       646/646
(100 %)
1 diff
(99.9 %id)
BM849961 stomach .h 626 to 1239 1 to 614       614/614
(100 %)
1 diff
(99.9 %id)
BM851038 stomach .h 626 to 1075 1 to 450       450/450
(100 %)
1 diff
(99.8 %id)
BM851066 stomach .h 626 to 1090 1 to 465       465/465
(100 %)
1 diff
(99.8 %id)
BM793709 Ascites, stomach .h 634 to 1185 1 to 552       552/552
(100 %)
2 diff
(99.7 %id)
BM821940 stomach .h 643 to 1100 1 to 458       458/458
(100 %)
1 diff
(99.8 %id)
TI_149310464   .h 654 to 1471 903 to 90   AAA   814/943
(86 %)
14 diff
(98.6 %id)
BM786696 Ascites, stomach .h 662 to 1280 1 to 619       619/619
(100 %)
1 diff
(99.9 %id)
BQ345080 nervous_tumor .h 672 to 1248 25 to 601       577/606
(95 %)
41 diff
(93.3 %id)
BG253827 adenocarcinoma, cell line, Prostate .h 683 to 1460 1 to 774       774/1033
(74 %)
25 diff
(97.6 %id)
BP213024 cerebrum .h 684 to 1197 1 to 514       514/569
(90 %)
8 diff
(98.6 %id)
BM851077 stomach .h 684 to 1174 1 to 489       489/489
(100 %)
4 diff
(99.2 %id)
BG951157 colon .h 705 to 1045 86 to 425       340/425
(80 %)
6 diff
(98.6 %id)
BQ683660 melanotic melanoma, cell line, skin .h 715 to 1455 1 to 742       742/954
(77 %)
24 diff
(97.5 %id)
BG951159 colon .h 716 to 1084 1 to 369       369/369
(100 %)
6 diff
(98.4 %id)
CA448066 Chondrosarcoma, Left Pubic Bone .h 717 to 1471 772 to 19   AAA   754/754
(100 %)
2 diff
(99.8 %id)
BM990482 lung, Metastatic Chondrosarcoma .h 718 to 1471 772 to 19   tiling clone, AAA   754/754
(100 %)
1 diff
(99.9 %id)
BM825497 Ascites, stomach .h 718 to 1309 1 to 592       592/592
(100 %)
0 diff
(100 %id)
BQ018232 lung, Metastatic Chondrosarcoma .h 719 to 1471 764 to 19   AAA   746/748
(99 %)
11 diff
(98.6 %id)
AA152274 uterus .h 724 to 1297 1 to 576       576/579
(99 %)
9 diff
(98.5 %id)
AA489563   .h 726 to 1070 1 to 345   fully sequenced,   345/345
(100 %)
0 diff
(100 %id)
BQ683928 melanotic melanoma, cell line, skin .h 728 to 1456 2 to 731   AAA   730/731
(99 %)
6 diff
(99.2 %id)
AA126197 uterus .h 730 to 1090 1 to 364       364/372
(97 %)
5 diff
(98.7 %id)
TI_154103752   .h 742 to 1471 804 to 78   AAA   727/803
(90 %)
16 diff
(98.1 %id)
T87982 liver and spleen .h 750 to 1088 1 to 343       343/343
(100 %)
8 diff
(97.7 %id)
BM691317 eye, RPE and Choroid .h 766 to 1026 2 to 262   fully sequenced,   261/262
(99 %)
5 diff
(98.1 %id)
BQ773407 Chondrosarcoma Cell line .h 782 to 1471 704 to 19   AAA   686/686
(100 %)
5 diff
(99.3 %id)
CA420713 Bone, Enchondroma cell line .h 782 to 1471 707 to 19   AAA   689/689
(100 %)
1 diff
(99.9 %id)
T25101   .h 786 to 1020 1 to 233       233/237
(98 %)
3 diff
(98.8 %id)
BG031131 breast, mammary adenocarcinoma, cell line .h 787 to 1496 12 to 720       709/735
(96 %)
15 diff
(98.0 %id)
BU688760 lung .h 789 to 1471 701 to 19   AAA   683/683
(100 %)
1 diff
(99.9 %id)
CD743060 Alveolar Macrophage, lung .h 789 to 1455 684 to 19   AAA   666/666
(100 %)
3 diff
(99.6 %id)
CA307599 Alveolar Macrophage, lung .h 799 to 1455 675 to 19   AAA   657/657
(100 %)
2 diff
(99.7 %id)
CF124814 CNCAP(3)T-225 cell line, Prostate .h 803 to 1338 61 to 596       536/596
(89 %)
6 diff
(99.0 %id)
TI_154185194   .h 803 to 1455 130 to 782   AAA   653/706
(92 %)
6 diff
(99.2 %id)
CD369954 Alveolar Macrophage, lung .h 804 to 1455 666 to 19   AAA   648/648
(100 %)
5 diff
(99.3 %id)
BM994828 lung, Metastatic Chondrosarcoma .h 809 to 1471 677 to 19   AAA   659/659
(100 %)
4 diff
(99.4 %id)
CA309801 Alveolar Macrophage, lung .h 825 to 1471 663 to 19   AAA   645/645
(100 %)
4 diff
(99.4 %id)
BE878200 large cell carcinoma, undifferentiated, lung .h 841 to 1458 1 to 618       618/619
(99 %)
7 diff
(98.9 %id)
FN057091 breast carcinoma .h 885 to 963 1 to 81       81/82
(98 %)
4 diff
(95.2 %id)
AA040737 uterus .h 889 to 1094 1 to 205   fully sequenced,   205/205
(100 %)
3 diff
(98.6 %id)
AA136347 uterus .h 890 to 1136 1 to 247   fully sequenced,   247/247
(100 %)
2 diff
(99.2 %id)
AI809717 pooled .h 908 to 1473 566 to 1       566/566
(100 %)
2 diff
(99.7 %id)
CA313032 Human Lung Epithelial cells, lung .h 918 to 1471 572 to 19   AAA   554/569
(97 %)
4 diff
(99.3 %id)
CA445885 Chondrosarcoma, Left Pelvis .h 956 to 1471 534 to 19   AAA   516/516
(100 %)
1 diff
(99.9 %id)
AA707665 liver and spleen .h 968 to 1462 494 to 1       494/494
(100 %)
3 diff
(99.4 %id)
AI469931 pooled .h 968 to 1467 506 to 8       499/506
(98 %)
0 diff
(100 %id)
BU618487 Cell Line, Chondrosarcoma .h 971 to 1471 519 to 19   AAA   501/571
(87 %)
5 diff
(99.2 %id)
BG033284 breast, mammary adenocarcinoma, cell line .h 975 to 1471 1 to 497   AAA   497/497
(100 %)
0 diff
(100 %id)
AI138651 heart .h 978 to 1471 506 to 13   AAA   494/494
(100 %)
2 diff
(99.6 %id)
W39687 senescent fibroblast .h 983 to 1341 1 to 358       358/409
(87 %)
3 diff
(99.3 %id)
AJ711554 heart .h 993 to 1458 21 to 486       466/494
(94 %)
2 diff
(99.6 %id)
AI888435 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .h 995 to 1458 464 to 1       464/464
(100 %)
1 diff
(99.8 %id)
AI312564 lung .h 996 to 1471 475 to 1       475/475
(100 %)
3 diff
(99.4 %id)
BM662359 eye, RPE and Choroid .h 996 to 1469 493 to 20   fully sequenced,   474/493
(96 %)
0 diff
(100 %id)
N98226 lung .h 1001 to 1473 467 to 1   fully sequenced,   467/467
(100 %)
15 diff
(96.8 %id)
EL950062 eyeball .h 1007 to 1452 14 to 459       446/459
(97 %)
6 diff
(98.7 %id)
AA654336 epithelium (cell line), Prostate .h 1010 to 1474 469 to 6       464/469
(98 %)
0 diff
(100 %id)
BM692532 eye, human retina .h 1012 to 1464 1 to 453       453/453
(100 %)
0 diff
(100 %id)
AI143779 heart .h 1013 to 1449 437 to 1       437/437
(100 %)
1 diff
(99.8 %id)
FN093582 breast carcinoma .h 1019 to 1090 1 to 72       72/73
(98 %)
1 diff
(98.7 %id)
AI298383 carcinoid, lung .h 1024 to 1470 447 to 1       447/447
(100 %)
3 diff
(99.4 %id)
BM692416 eye, human retina .h 1025 to 1470 9 to 454   fully sequenced,   446/454
(98 %)
2 diff
(99.6 %id)
AI694301 pooled .h 1032 to 1478 450 to 4       447/450
(99 %)
0 diff
(100 %id)
AI244911 Kidney .h 1035 to 1457 423 to 1       423/423
(100 %)
4 diff
(99.1 %id)
AA485952   .h 1040 to 1469 445 to 16   fully sequenced,   430/445
(96 %)
0 diff
(100 %id)
AI032620 parathyroid gland, parathyroid tumor .h 1042 to 1474 437 to 5       433/437
(99 %)
0 diff
(100 %id)
AI679137 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .h 1042 to 1455 414 to 1       414/414
(100 %)
0 diff
(100 %id)
AW170455 cervix, tumor .h 1045 to 1445 401 to 1       401/401
(100 %)
4 diff
(99.1 %id)
AI679711 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .h 1046 to 1455 410 to 1       410/410
(100 %)
0 diff
(100 %id)
AA132758.
matches multiple genes
colon, tumor .h 1051 to 1474 428 to 4     also hits gene spubly 425/428
(99 %)
0 diff
(100 %id)
AA666206   .h 1061 to 1454 393 to 1       393/393
(100 %)
1 diff
(99.8 %id)
AA040738 uterus .h 1064 to 1460 399 to 1   fully sequenced,   399/399
(100 %)
4 diff
(99.0 %id)
AA729314 pooled germ cell tumors .h 1064 to 1458 406 to 12       395/406
(97 %)
0 diff
(100 %id)
AA593284 Kidney, kidney tumor .h 1069 to 1474 408 to 3       406/408
(99 %)
0 diff
(100 %id)
AA947666 pooled germ cell tumors .h 1069 to 1471 403 to 1       403/403
(100 %)
0 diff
(100 %id)
AA888007 colon, colon tumor RER+ .h 1070 to 1474 408 to 4       405/408
(99 %)
0 diff
(100 %id)
AA933752 pooled germ cell tumors .h 1070 to 1420 350 to 1       350/350
(100 %)
2 diff
(99.5 %id)
AA968754 pooled germ cell tumors .h 1075 to 1471 410 to 14   AAA   397/397
(100 %)
0 diff
(100 %id)
AI000524 breast .h 1077 to 1472 396 to 1       396/396
(100 %)
2 diff
(99.5 %id)
AI016860 pooled .h 1085 to 1478 394 to 1       394/394
(100 %)
4 diff
(99.0 %id)
AI220888 placenta .h 1095 to 1451 357 to 1       357/357
(100 %)
2 diff
(99.5 %id)
AA609636   .h 1098 to 1455 368 to 11   AAA   358/358
(100 %)
0 diff
(100 %id)
AA136260 uterus .h 1106 to 1455 360 to 1   fully sequenced,   360/360
(100 %)
16 diff
(95.6 %id)
AA127219 uterus .h 1115 to 1471 359 to 1       359/373
(96 %)
2 diff
(99.5 %id)
BM766386 Ascites, stomach .h 1122 to 1449 1 to 329       329/329
(100 %)
10 diff
(97.0 %id)
AA809707 colon .h 1136 to 1471 351 to 16   AAA   336/336
(100 %)
0 diff
(100 %id)
AA877953 pharynx, squamous cell carcinoma .h 1143 to 1456 314 to 1       314/314
(100 %)
0 diff
(100 %id)
AA150440.
matches multiple genes
uterus .h 1144 to 1471 343 to 16   AAA also hits gene koykoybu 328/333
(98 %)
0 diff
(100 %id)
AW883191 ovary .h 1151 to 1464 1 to 313       313/314
(99 %)
5 diff
(98.5 %id)
AA628266   .h 1178 to 1471 294 to 1       294/294
(100 %)
1 diff
(99.7 %id)
AA724342 parathyroid gland, parathyroid tumor .h 1201 to 1471 283 to 13   AAA   271/271
(100 %)
0 diff
(100 %id)
BF760383 colon .h 1205 to 1428 1 to 227       227/227
(100 %)
10 diff
(95.6 %id)
AI244043 Kidney .h 1261 to 1458 199 to 2       198/199
(99 %)
0 diff
(100 %id)
BG978419 colon_normal .h 1271 to 1435 1 to 164       164/174
(94 %)
6 diff
(96.6 %id)
AI159932 heart .h 1273 to 1471 210 to 12   AAA   199/199
(100 %)
0 diff
(100 %id)
AA676487   .h 1278 to 1471 204 to 11   AAA   194/194
(100 %)
0 diff
(100 %id)
AA926709 pooled .h 1278 to 1459 188 to 7       182/188
(96 %)
0 diff
(100 %id)
BM673657 eye, human retina .h 1291 to 1469 207 to 29   fully sequenced,   179/207
(86 %)
0 diff
(100 %id)
AA235652 ovarian tumor, ovary .h 1293 to 1455 163 to 1       163/163
(100 %)
0 diff
(100 %id)
DC304456 cerebellum .i 1 to 577 1 to 577   tiling clone,   577/577
(100 %)
1 diff
(99.9 %id)
DC338202 subthalamic nucleus .i 17 to 557 1 to 541       541/541
(100 %)
0 diff
(100 %id)
DC361020   .i 29 to 587 1 to 559       559/559
(100 %)
1 diff
(99.9 %id)
CN423137 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .i 301 to 777 1 to 477   tiling clone,   477/477
(100 %)
0 diff
(100 %id)
BF309574 muscle, rhabdomyosarcoma .j 1 to 811 2 to 808 R145E R146E R147D R149E R150E ... tiling clone,   808/897
(90 %)
25 diff
(97.3 %id)
BG826315 muscle, rhabdomyosarcoma .j 1 to 764 2 to 775 T140D A141S R142K Q143A Q144A ... tiling clone,   775/927
(83 %)
25 diff
(97.4 %id)
DA737244   .k 1 to 825 2 to 827 K102X tiling clone, fully sequenced, capped   826/826
(100 %)
7 diff
(99.2 %id)
BM798226 Ascites, stomach .k 445 to 808 1 to 364   tiling clone,   364/364
(100 %)
6 diff
(98.4 %id)
AU154284   .k 805 to 1387 579 to 1   tiling clone, fully sequenced,   579/579
(100 %)
10 diff
(98.3 %id)
BP309837 brain .l 1 to 582 2 to 583   tiling clone,   583/583
(100 %)
1 diff
(99.9 %id)
BP371153 testis .l 5 to 569 1 to 565       565/565
(100 %)
1 diff
(99.9 %id)
CB108748 Liver .l 56 to 652 1 to 597 K123X K130R R153M tiling clone,   597/597
(100 %)
2 diff
(99.7 %id)
CN423139 embryonic stem cells, cell lines H1, H7, andH9 .m 1 to 691 1 to 691 exact tiling clone,   691/691
(100 %)
2 diff
(99.8 %id)
AA075905   .m 4 to 356 1 to 354       354/354
(100 %)
4 diff
(98.9 %id)
AW015843   .m 188 to 638 451 to 1       451/451
(100 %)
6 diff
(98.7 %id)
DR763384 embryonic stem .m 220 to 934 1 to 715   tiling clone,   715/715
(100 %)
1 diff
(99.9 %id)
W21409 lung .m 255 to 406 1 to 152       152/152
(100 %)
0 diff
(100 %id)
AA071552   .m 975 to 1333 364 to 1   tiling clone,   364/398
(91 %)
4 diff
(99.0 %id)
N93577 lung .m 1187 to 1407 222 to 1   tiling clone,   222/229
(96 %)
3 diff
(98.7 %id)
BP370817 testis .n 1 to 559 4 to 562 exact tiling clone,   562/562
(100 %)
0 diff
(100 %id)
BU663972 blood .n 91 to 549 1 to 459       459/459
(100 %)
5 diff
(99.0 %id)
BP245699 Kidney .o 1 to 581 2 to 582 exact tiling clone,   582/582
(100 %)
7 diff
(98.8 %id)
DA237428 brain .p 1 to 553 2 to 554 exact tiling clone, capped   553/553
(100 %)
0 diff
(100 %id)
BG231844 blood, lymphocyte .q-u 1 to 495 495 to 1 exact tiling clone,   495/495
(100 %)
0 diff
(100 %id)
BM713919 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .r 1 to 330 1 to 330 exact tiling clone, fully sequenced,   350/350
(100 %)
6 diff
(98.3 %id)
BM676535 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .r 141 to 333 211 to 19 exact tiling clone, fully sequenced, AAA   193/193
(100 %)
0 diff
(100 %id)
CV332854 head_neck .s-u 1 to 225 6 to 230 exact tiling clone,   230/230
(100 %)
11 diff
(95.3 %id)
CV332898 head_neck .s-u 1 to 225 6 to 230 exact     230/230
(100 %)
11 diff
(95.3 %id)
AA091236   Gene ZCCHC17, variant not shown         Suspected internal deletion, this clone was ignored    
CD627973   Gene ZCCHC17, variant not shown         This clone was ignored    
CD687355 normal nasopharynx Gene ZCCHC17, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q-u, .r, .s-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI